Skip to main content

Table 6 Outcomes of COVID-19 infection (N = 79)

From: “Online survey of COVID-19 immunization and infection in patients with systemic juvenile idiopathic arthritis and adult-onset still’s disease.”

 

Asymptomatic

Mild/Moderate

Hospitalization

ICU

Other

Blank

Disease Flare

sJIA

       

≤ 1 dose*

N = 45

11 (24%)

30 (67%)

 

1 (2%)**

2 (4%)***

1 (2%)

20 (45%)

2 doses

N = 13

3 (23%)

10 (76%)

    

3 (23%)

3 doses

N = 11

1 (9%)

8 (72%)

1 (9%)

  

1 (9%)

2 (18%)

4 doses

N = 1

 

1 (100%)

     

AOSD

       

≤ 1 dose*

N = 1

 

1 (100%)

     

2 doses

N = 3

 

3 (100%)

    

1 (33%)

3 doses

N = 4

 

4 (100%)

    

2 (50%)

4 doses

N = 1

 

2 (100%)

     
  1. *Patients who had COVID-19 without any prior doses of the immunization and patients who had COVID after the first dose of a 2-dose immunization regimen.
  2. ** This patient later died of disease flare, which was triggered by the infection.
  3. *** Two patients reported that Covid triggered sJIA and MAS.
Back to article page

Pediatric Rheumatology

ISSN: 1546-0096